Liu He Selected Research

Liu He Research Topics

Disease

31	Atrial Fibrillation 04/2024 - 04/2019
18	Neoplasms (Cancer) 01/2024 - 12/2008
10	Stroke (Strokes) 10/2023 - 06/2011
7	Hemorrhage 12/2023 - 12/2020
6	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 03/2016
4	Pain (Aches) 10/2023 - 10/2016
4	Thromboembolism 10/2023 - 04/2019
4	Ischemic Stroke 01/2023 - 01/2021
4	Heart Failure 01/2022 - 04/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 12/2008
3	Stomach Neoplasms (Stomach Cancer) 01/2024 - 08/2020
3	Embolism (Embolus) 12/2023 - 05/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 12/2022
2	Cognitive Dysfunction 02/2024 - 01/2021
2	Acne Vulgaris 02/2024 - 02/2023
2	Postoperative Pain 10/2023 - 01/2022
2	Diabetes Mellitus 12/2022 - 07/2020
2	Fibrosis (Cirrhosis) 07/2022 - 11/2015
2	Acute Coronary Syndrome 01/2022 - 07/2020
2	Thyroid Neoplasms (Thyroid Cancer) 07/2021 - 01/2015
2	Wounds and Injuries (Trauma) 01/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 10/2017 - 03/2016
2	Obesity 08/2017 - 06/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015 - 08/2015
2	Flushing 08/2015 - 11/2012
2	Type 2 Diabetes Mellitus (MODY) 09/2009 - 06/2009
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2024
1	Epilepsy (Aura) 01/2024
1	Bundle-Branch Block (Fascicular Block) 01/2024
1	Melanoma (Melanoma, Malignant) 10/2023
1	Transient Ischemic Attack 10/2023
1	Death (Near-Death Experience) 10/2023
1	Autoimmune Diseases (Autoimmune Disease) 07/2023
1	Frailty 01/2023
1	Lymphoma (Lymphomas) 01/2023

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2021
8	AnticoagulantsIBA 01/2022 - 04/2019
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2006
4	Peptides (Polypeptides)IBA 02/2024 - 01/2021
4	Anti-Arrhythmia AgentsIBA 01/2023 - 06/2019
4	Neuroprotective AgentsIBA 01/2019 - 03/2016
3	LipidsIBA 04/2022 - 09/2009
3	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2019
3	CholesterolIBA 01/2021 - 06/2011
3	InflammasomesIBA 11/2019 - 01/2018
3	Heparin (Liquaemin)FDA LinkGeneric 03/2016 - 11/2012
2	NAD (NADH)IBA 03/2024 - 12/2022
2	Sodium-Glucose Transport ProteinsIBA 12/2023 - 11/2023
2	Ropivacaine (Naropin)FDA LinkGeneric 10/2023 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2023 - 01/2022
2	Polysaccharides (Glycans)IBA 02/2023 - 12/2022
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2020
2	Indicators and Reagents (Reagents)IBA 01/2023 - 04/2011
2	CytokinesIBA 10/2022 - 11/2015
2	oxidized low density lipoproteinIBA 04/2022 - 01/2021
2	LDL CholesterolIBA 04/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2011
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 07/2020
2	ChitosanIBA 10/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 09/2009
2	HDL CholesterolIBA 01/2021 - 06/2011
2	Therapeutic UsesIBA 01/2021 - 10/2016
2	N(4)-oleylcytosine arabinosideIBA 01/2021 - 04/2019
2	Sodium Chloride FDA LinkGeneric 08/2015 - 11/2012
2	Saline SolutionIBA 08/2015 - 11/2012
2	SolutionsIBA 08/2015 - 11/2012
1	Topoisomerase InhibitorsIBA 01/2024
1	Epirubicin (Ellence)FDA LinkGeneric 01/2024
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2024
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2024
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2024
1	PepsinogensIBA 01/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023
1	Troponin T (Troponin T1)IBA 10/2023
1	pro-brain natriuretic peptide (1-76)IBA 10/2023
1	OligopeptidesIBA 02/2023
1	Testosterone (Sustanon)FDA Link 02/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2023
1	Hyaluronic Acid (Hyaluronan)IBA 02/2023
1	AZD4547IBA 02/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2023
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2023
1	Aldo-Keto Reductase Family 1 Member C3IBA 02/2023

Therapy/Procedure

17	Catheter Ablation 04/2024 - 01/2021
8	Therapeutics 10/2023 - 01/2020
6	Radiofrequency Ablation 04/2024 - 09/2020
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2021
2	Catheters 10/2023 - 08/2015
2	Immunotherapy 01/2023 - 01/2022
2	Neoadjuvant Therapy 10/2017 - 08/2017
1	Baths 03/2024
1	Cognitive Training 02/2024
1	Electrodes (Electrode) 01/2024
1	Patient Readmission 12/2023
1	Analgesia 10/2023